RARX
Adage Capital Partners’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-600,000
| Closed | -$14.2M | – | 786 |
|
|
2019
Q3 | $14.2M | Buy |
600,000
+200,000
| +50% | +$4.73M | 0.03% | 447 |
|
|
2019
Q2 | $12M | Buy |
400,000
+50,000
| +14% | +$1.5M | 0.03% | 496 |
|
|
2019
Q1 | $7.84M | Buy |
350,000
+150,000
| +75% | +$3.36M | 0.02% | 558 |
|
|
2018
Q4 | $3.64M | Buy |
+200,000
| New | +$3.64M | 0.01% | 633 |
|
|
2017
Q4 | – | Sell |
-68,000
| Closed | -$993K | – | 774 |
|
|
2017
Q3 | $993K | Sell |
68,000
-47,000
| -41% | -$686K | ﹤0.01% | 691 |
|
|
2017
Q2 | $2.16M | Sell |
115,000
-26,000
| -18% | -$487K | 0.01% | 662 |
|
|
2017
Q1 | $3M | Sell |
141,000
-34,000
| -19% | -$724K | 0.01% | 646 |
|
|
2016
Q4 | $2.66M | Buy |
+175,000
| New | +$2.66M | 0.01% | 641 |
|